It promotes the formation of HCC lesions by regulating miR-433-FXYD3-PI3K-Akt signaling.128 Therefore, studies on this pathway and its related pathways may be crucial to increase the anticancer efficacies of clinical PI3K/Akt inhibitors. The gene discussed is PIK3CD; the disease is hepatocellular carcinoma.